Results Healthcare   |   Results International

Insights

We add value by understanding our sectors inside out, and release regular industry research and reports

The CMO industry suddenly becomes very exciting, again!

By Kevin Bottomley 07 Jun 2017

The CMO industry is currently growing strongly (globally high single digits, with some specialist subsectors in double digit grow) http://resultshealthcare.com/insight/pharma-biotech-2017/  fuelled by pharma and biotech’s strategy of outsourcing and continued growth in demand for pharmaceuticals (both innovative and generic). However, the industry has continued to be fragmented with no dominant players.  There are many historical and practical reasons for this which we have detailed in our white paper on this sector.  Yesterday’s announcement that the Carlyle Group and GTCR are to acquire AMRI http://ir.amriglobal.com/releasedetail.cfm?ReleaseID=1029167 following on from Thermo Fisher’s acquisition of Patheon (announced last month http://news.patheon.com/press-release/corporate/thermo-fisher-scientific-acquire-patheon-leading-contract-development-and) confirms both the long term growth potential of the sector and the opportunity for consolidation.

There have been several drivers for consolidation over the years to create companies with very significant market share through M&A, however no clear winner has emerged from these efforts. It will be interesting to see if this is the start of a new attempt to produce a few players of very significant scale in this sector.

Kevin Bottomley

Partner

Contact Kevin

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office